OSE Immunotherapeutics – executive interview

Published on 13 May 2020

OSE Immunotherapeutics is an immunotherapy company based in Nantes and Paris, France, and is listed on the Euronext Paris exchange. It is developing immunotherapies for the treatment of solid tumours and autoimmune diseases and has established several partnerships with large pharma companies.

In this video, the company’s chief executive officer Alexis Peyroles provides an overview of R&D progress, including the recently announced COVID-19 prophylactic vaccine programme and expected newsflow.

Share this with friends and colleagues